TANFAC Industries Reports 6.3% Revenue Growth in Q1 FY27; Turns Net Debt-Free to Accelerate HFC-32 Expansion

What Happened ?

Key details

Financial Performance:

TANFAC continued to deliver revenue growth despite a challenging operating environment.

• Revenue increased 6.3% YoY to ₹187.2 crore.
• Gross Profit stood at ₹68.9 crore.
• EBITDA was ₹28.6 crore with a margin of 15.3%.
• PAT came in at ₹16.8 crore, reflecting higher raw material costs and deferred tax adjustments.

Margin Pressure Remained Temporary:

Profitability during the quarter was impacted by external factors rather than operational weakness.

Major reasons included:

• Higher sulphur prices increased raw material costs.
• Elevated fuel expenses due to geopolitical tensions in West Asia.
• Temporary disruptions across parts of the fluorochemical supply chain.
• Deferred tax adjustments impacted reported earnings.

Management expects pricing pass-through mechanisms to offset higher sulphur costs over the normal 30–45 day pricing cycle, while tax rates are expected to normalise in the coming quarters. 

Strengthened Balance Sheet Through Capital Raise:

One of the most significant developments during the quarter was the company’s successful fundraising.

Key developments:

• Successfully raised ₹250 crore through a Qualified Institutional Placement (QIP).
• Proposed approximately ₹100 crore preferential issue by promoter Anupam Rasayan India Limited.
• TANFAC has become net debt-free following the capital raise.
• Improved financial flexibility to pursue downstream fluorochemical expansion. 

HFC-32 Project Progress:

The company’s flagship expansion project continues to advance as planned.

Project highlights:

• 20,000 MTPA HFC-32 refrigerant gas plant.
• Total project investment of approximately ₹390 crore.
• Around 81% of the project budget has been committed.
• Approximately 75% of civil works have been completed.
• Basic engineering has been completed and equipment orders have been placed.
• Commercial commissioning remains targeted for the end of Q3 FY27, with production expected from January 2027.

Integrated Fluorochemical Growth Strategy:

TANFAC continues expanding its presence across the fluorochemical value chain.

The company currently operates:

• 29,700 MTPA Anhydrous Hydrofluoric Acid (AHF) capacity.
• 20,000 MTPA Solar Grade DHF capacity.
• 100,000 MTPA Sulphuric Acid/Oleum capacity.
• 5,000 MTPA Specialty Inorganic Fluorides capacity.

Future expansion is focused on:

• HFC-32 refrigerant gases.
• Fluorinated organic intermediates.
• Next-generation fluorochemicals.
• Stronger backward integration.

Strong Industry Position:

TANFAC remains one of India’s established fluorochemical manufacturers with:

• Over 40 years of operating history.
• Integrated manufacturing facility in Cuddalore, Tamil Nadu.
• Manufacturing capacity of approximately 135,000 MTPA.
• Presence across 105+ customers in more than 10 countries.
• FY26 revenue of ₹711 crore with ₹112 crore EBITDA and ₹70 crore PAT.

Management Commentary:

Management stated that the successful QIP and proposed promoter investment reflect strong confidence in TANFAC’s long-term strategy. While short-term profitability has been impacted by elevated sulphur prices and geopolitical challenges, the strengthened balance sheet and ongoing HFC-32 expansion position the company for sustainable long-term growth and downstream value creation.

Note:

• The investor presentation highlights that TANFAC’s current quarter should be viewed in the context of its broader transformation strategy.
• Although temporary cost inflation affected margins, the company has significantly strengthened its financial position, accelerated investment in high-value fluorochemicals and continues executing one of India’s key HFC-32 expansion projects.
• Successful commissioning of the new plant and stabilisation of raw material costs could materially improve growth and profitability over the medium term. 

Risk Analysis

Summary:

• The company’s long-term outlook remains favourable, but near-term profitability depends on raw material prices and timely execution of expansion projects.

Key Risks:

• Sustained volatility in sulphur prices may continue to pressure margins.
• Geopolitical developments could affect fuel costs and supply chains.
• Delays in commissioning the HFC-32 project could postpone revenue generation.
• Demand fluctuations in global fluorochemical markets may impact growth.
• Execution risks remain around large-scale capex and downstream expansion. 

Worst Case:

• If geopolitical disruptions persist, sulphur prices remain elevated and the HFC-32 project experiences delays, profitability could remain under pressure despite the company’s stronger balance sheet.

Risk Level: Medium

Company Commentary

• Revenue grew 6.3% YoY to ₹187.2 crore.
• Successfully completed a ₹250 crore QIP, with an additional ~₹100 crore promoter-led preferential issue proposed.
• The company has become net debt-free, strengthening its financial flexibility.
• The 20,000 MTPA HFC-32 refrigerant gas project remains on track for commissioning by the end of Q3 FY27.
• Management expects temporary cost pressures to ease while strategic expansion initiatives support long-term value creation.